News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Nico Gagelmann: Fast and furious: CAR-T cells in multiple myeloma
Aug 8, 2024, 10:11

Nico Gagelmann: Fast and furious: CAR-T cells in multiple myeloma

Nico Gagelmann,  shared a post on X:

“Finally published

‘Fast and furious: Changing gears on the road to cure with chimeric antigen receptor T cells in multiple myeloma’

Seminars in Hematology.

Authors: Nico Gagelmann, Maximilian Merz.”

Nico Gagelmann: Fast and furious: CAR-T cells in multiple myeloma

Source: Nico Gagelmann/X

cancer Maximilian Merz multiple myeloma Nico Gagelmann OncoDaily Oncology
Special Coverage
Blog
Feb 21, 2025, 09:45
Michelle Kirschner: New programming at the Cancer Survivorship Provider Network
Science
Feb 21, 2025, 09:39
M. Bilal Abid: Excited to present at the UT San Antonio MD Anderson Cancer Center
Blog
Feb 21, 2025, 09:35
UICC is seeking an Executive Director to lead the ATOM Coalition in Geneva
Blog
Feb 21, 2025, 09:18
Belén Garijo: A very important evolution of Merck Group's Executive Board
Blog
Feb 21, 2025, 09:07
Karen Knudsen: Integrating technology into clinical practice
Blog
Feb 21, 2025, 09:00
ICCD 2025 Event Highlights: Speakers’ Quote Series - SIOP Europe
Blog
Feb 21, 2025, 08:48
Emily Drake: Delivery of palliative and end-of-life care for AYAs living with cancer
Blog
Feb 21, 2025, 08:19
Chibuike Okafor: How Amgen Defeated the ‘Undruggable’ KRAS
Insight
Feb 21, 2025, 06:20
Gustavo Viani: New Evidence on Elective CTV in Early Anal Cancer
Blog
Feb 21, 2025, 06:10
Afreen Shariff: Start-ups are about persistence, grit and being comfortable with being uncomfortable
Radiotherapy
Feb 21, 2025, 04:51
Radiotherapy For Breast Cancer: Types, Success Rate, Side Effects And More
Library
Feb 20, 2025, 16:36
New Paper Alert: Systemic management of advanced HCC: an increasingly complex game